September 22, 2025

Vietnam Enterprise Investments reports interim results with NAV growth and narrowed discount

Vietnam Enterprise Investments has published its Interim Results for the six months to 30 June 2025. NAV per share rose 0.9% in US$ terms, while the share price increased 9.0%, narrowing the discount to 14.9%...

AstraZeneca’s Tezspire recommended for EU approval in chronic rhinosinusitis with nasal polyps

The European Medicines Agency’s CHMP has issued a positive opinion recommending approval of Tezspire (tezepelumab) for adult patients with chronic rhinosinusitis with nasal polyps...

Centrica appoints Frank Mastiaux as Non-Executive Director

Centrica has appointed Frank Mastiaux as a Non-Executive Director with effect from 22 September 2025. He will also join the Safety, Environment and Sustainability Committee...

Manx Financial reports 16% rise in interim PPBT to £4.1m

Manx Financial has published its Interim Results for the six months to 30 June 2025, reporting a 16% increase in Profit Before Tax to £4.1 million. Net loan book growth reached £392.6 million, operating income rose to £18.4 million, and profit attributable to owners increased 55% to £3.7 million..

Ilika launches PRIMED programme with JLR and Oxford University

Ilika has commenced its PRIMED programme, supported by the Advanced Propulsion Centre UK, to accelerate the commercialisation of solid-state battery technology...

Manx Financial’s Conister Bank enters £2m convertible loan note agreement with Fiinu

Manx Financial Group PLC (AIM: MFX) has announced that its subsidiary, Conister Bank, has entered into a £2 million convertible loan note agreement with AIM-listed Fiinu plc...
Search

Funds

September 22, 2025

Vietnam Enterprise Investments reports interim results with NAV growth and narrowed discount

Vietnam Enterprise Investments has published its Interim Results for the six months to 30 June 2025. NAV per share rose 0.9% in US$ terms, while the share price increased 9.0%, narrowing the discount to 14.9%...

AstraZeneca’s Tezspire recommended for EU approval in chronic rhinosinusitis with nasal polyps

The European Medicines Agency’s CHMP has issued a positive opinion recommending approval of Tezspire (tezepelumab) for adult patients with chronic rhinosinusitis with nasal polyps...

Centrica appoints Frank Mastiaux as Non-Executive Director

Centrica has appointed Frank Mastiaux as a Non-Executive Director with effect from 22 September 2025. He will also join the Safety, Environment and Sustainability Committee...

Manx Financial reports 16% rise in interim PPBT to £4.1m

Manx Financial has published its Interim Results for the six months to 30 June 2025, reporting a 16% increase in Profit Before Tax to £4.1 million. Net loan book growth reached £392.6 million, operating income rose to £18.4 million, and profit attributable to owners increased 55% to £3.7 million..

Ilika launches PRIMED programme with JLR and Oxford University

Ilika has commenced its PRIMED programme, supported by the Advanced Propulsion Centre UK, to accelerate the commercialisation of solid-state battery technology...

Manx Financial’s Conister Bank enters £2m convertible loan note agreement with Fiinu

Manx Financial Group PLC (AIM: MFX) has announced that its subsidiary, Conister Bank, has entered into a £2 million convertible loan note agreement with AIM-listed Fiinu plc...
Search

Funds

September 22, 2025

FTSE 100

Funds